MedPath

CLINICAL, MICROBIOLOGICAL AND IMMUNOLOGICAL EVALUATION OF THE EFFICACY OF ORALY ADMINISTERED PROBIOTIC BACILLUS COAGULANS AND STREPTOCOCCUS SALIVARIUS AS AN ADJUVANT TO SCALING AND ROOT PLANING IN PERIODONTITIS PATIENTS: A RANDOMIZED CLINICAL STUDY

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2022/08/044650
Lead Sponsor
nique Biotech Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a. Age between 30-65years.

b. Patients with stage II and stage III periodontitis according to AAP 2017 classification will be included.10

c)30% or more of sites with probing pocket depth (PPD>= 4mm and CAL>=4mm

d)A minimum of five teeth with at least one site with CAL and PPD>=4mm.

Exclusion Criteria

a. Antimicrobial therapy in the previous three months

b. Presence of systemic conditions

c. History of smoking

d. Need of prophylactic antibiotic therapy for routine dental procedures.

e. long term administration of anti-inflammatory medications.

f. Usage of probiotics in the past six months before the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Probing pocket depth assessed at six sites per tooth. <br/ ><br>Microbiological counts of Porphyromonas gingivalis <br/ ><br>Microbiological counts of Bacillus coagulans <br/ ><br>and Streptococcus salivarius <br/ ><br>Levels of IL6.Timepoint: BASELINE, 1 MONTH AND 3 MONTHS FOLLOWING PROBIOTIC AND PLACEBO INTERVENTIO
Secondary Outcome Measures
NameTimeMethod
Clinical Attachment Level CAL assessed at six sites per tooth. <br/ ><br>Plaque Index Silness and Loe 1964 <br/ ><br>Gingival Index Loe and Silness 1963 <br/ ><br>Timepoint: BASELINE, 1 MONTH AND 3 MONTHS FOLLOWING PROBIOTIC AND PLACEBO INTERVENTIO
© Copyright 2025. All Rights Reserved by MedPath